Tempus AI

By Tempus AI
· USA
Tempus AI — AI-assisted genomic profiling for oncology.
RAG / Knowledge AI
Oncology
Production
Not Formally Regulated
Regulatory status
Not Formally Regulated
Deployment
Production
Clinical role
Adjunct (decision support)
Headquarters
USA
AI type
RAG / Knowledge AI

Precise indication

AI-assisted genomic profiling for oncology.

Regulatory status

Not directly applicable — a genomic-profiling/diagnostics company, not a single regulated AI device.

Clinical evidence

Vendor-supported

Vendor press release citing recognition on TIME’s list of the 10 most influential health and life-science companies (2026).

Independent

TIME’s recognition is a third-party editorial judgment, not a clinical-outcomes study.

Real-world deployment

No specific clinical-deployment figure found in this research pass.

Interoperability

European status

Editorial verdict

Limits and uncertainties

Too broad a company profile to evaluate as a single AI tool without further, more specific research.

Sources

https://www.tempus.com/news/pr/tempus-named-to-times-list-of-the-10-most-influential-health-and-life-science-companies-of-2026/

This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate

At a glance
Vendor
Tempus AI
Headquarters
USA
AI type
RAG / Knowledge AI
Specialty
Clinical role
Adjunct (decision support)
CE marking
Notified body
EU AI Act
Data hosting
Last verified
Reviewed by
How we evaluate

Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.

A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.

Read the methodology →

Spotted an error?

Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.